- Home
- INEO vs CODX Comparison
INEO vs CODX Comparison
Compare INEO & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INEO
- CODX
- Stock Information
- Founded
- INEO 2022
- CODX 2013
- Country
- INEO Singapore
- CODX United States
- Employees
- INEO 139
- CODX N/A
- Industry
- INEO
- CODX Medical/Dental Instruments
- Sector
- INEO
- CODX Health Care
- Exchange
- INEO NYSE
- CODX Nasdaq
- Market Cap
- INEO 9.9M
- CODX 9.8M
- IPO Year
- INEO N/A
- CODX 2017
- Fundamental
- Price
- INEO $0.93
- CODX $0.25
- Analyst Decision
- INEO
- CODX Buy
- Analyst Count
- INEO 0
- CODX 2
- Target Price
- INEO N/A
- CODX $5.50
- AVG Volume (30 Days)
- INEO 84.6K
- CODX 1.4M
- Earning Date
- INEO 05-19-2025
- CODX 08-14-2025
- Dividend Yield
- INEO N/A
- CODX N/A
- EPS Growth
- INEO N/A
- CODX N/A
- EPS
- INEO 0.00
- CODX N/A
- Revenue
- INEO $58,333,000.00
- CODX $3,497,583.00
- Revenue This Year
- INEO N/A
- CODX N/A
- Revenue Next Year
- INEO N/A
- CODX $42.11
- P/E Ratio
- INEO $2,031.43
- CODX N/A
- Revenue Growth
- INEO N/A
- CODX N/A
- 52 Week Low
- INEO $0.47
- CODX $0.23
- 52 Week High
- INEO $8.27
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- INEO N/A
- CODX 38.51
- Support Level
- INEO N/A
- CODX $0.28
- Resistance Level
- INEO N/A
- CODX $0.29
- Average True Range (ATR)
- INEO 0.00
- CODX 0.02
- MACD
- INEO 0.00
- CODX -0.00
- Stochastic Oscillator
- INEO 0.00
- CODX 18.86
About INEO INNEOVA HOLDINGS LIMITED
INNEOVA Holdings Ltd is a Singapore-based provider of Original Equipment Manufacturer (OEM), third-party branded and in-house branded replacement parts for motor vehicles and non-vehicle combustion engines. The two segments include off- highway business segment and the other is On-Highway Business Segment.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.